ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

TTOO T2 Biosystems Inc

5.14
0.08 (1.58%)
2024年6月1日 - 終了
15分遅延
名称 銘柄コード 市場 種別
T2 Biosystems Inc TTOO NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.08 1.58% 5.14 09:00:00
始値 安値 高値 終値 前日終値
5.01 5.01 5.4122 5.14 5.06
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/2510:04EDGAR2Form S-3 - Registration statement under Securities Act of..
2024/5/2305:49EDGAR2Form 8-K - Current report
2024/5/2222:00GLOBET2 Biosystems Regains Compliance with Nasdaq Continued..
2024/5/2020:00EDGAR2Form 8-K - Current report
2024/5/1805:05GLOBET2 Biosystems Announces Closing of $8 Million Private..
2024/5/1520:00GLOBET2 Biosystems Announces $8 Million Private Placement Priced..
2024/5/1506:00GLOBET2 Biosystems Announces CRG’s Conversion from Preferred..
2024/5/1505:55EDGAR2Form RW - Registration Withdrawal Request
2024/5/1505:43EDGAR2Form 8-K - Current report
2024/5/1408:21EDGAR2Form SC 13D/A - General statement of acquisition of..
2024/5/1407:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/0808:46EDGAR2Form SC 13D/A - General statement of acquisition of..
2024/5/0805:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/0805:48EDGAR2Form 8-K - Current report
2024/5/0722:00GLOBET2 Biosystems Announces Letter of Intent to Enter Strategic..
2024/5/0706:27EDGAR2Form S-1/A - General form for registration of securities..
2024/5/0706:24EDGAR2Form 8-K - Current report
2024/5/0706:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/0705:34GLOBET2 Biosystems Announces First Quarter 2024 Financial Results
2024/5/0705:34GLOBET2 Biosystems Announces Commercial Expansion Through Middle..
2024/5/0705:29GLOBET2 Biosystems Announces the Conversion of an Additional $15..
2024/5/0620:48EDGAR2Form S-1/A - General form for registration of securities..
2024/4/2422:00GLOBET2 Biosystems to Report First Quarter 2024 Financial Results..
2024/4/1205:05GLOBET2 Biosystems Shareholders Vote for CRG Debt Conversion into..
2024/3/2822:00GLOBET2 Biosystems Announces Extension of Multi-Year Capital..
2024/3/2020:30GLOBET2 Biosystems Unveils T2Lyme Launch Plans and Provides..
2024/3/1922:00GLOBET2 Biosystems to Host Investor Call on March 20, 2024 to..
2024/3/1822:00GLOBET2 Biosystems Announces New Publication Highlighting the..
2024/3/1222:00GLOBET2 Biosystems Receives Extension to Comply with Nasdaq..
2024/3/0506:34EDGAR2Form DEF 14A - Other definitive proxy statements
2024/2/2806:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2806:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2806:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2106:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2106:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2106:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2106:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1707:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1707:00EDGAR2Form 8-K - Current report
2024/2/1606:49EDGAR2Form PRE 14A - Other preliminary proxy statements
2024/2/1606:47EDGAR2Form 8-K - Current report
2024/2/1606:06GLOBET2 Biosystems Announces Preliminary Fourth Quarter and Full..
2024/2/1606:04GLOBET2 Biosystems Announces Agreement with CRG for the..
2024/2/1606:02GLOBET2 Biosystems Announces Commercial Expansion Through..
2024/2/1410:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1223:00GLOBET2 Biosystems Receives FDA 510(k) Clearance for the Expanded..
2024/2/0806:05GLOBET2 Biosystems to Report Fourth Quarter and Full Year 2023..
2024/1/1823:00GLOBET2 Biosystems Announces Participation in NIH-funded..
2024/1/0606:00EDGAR2Form 8-K - Current report
2024/1/0406:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..

最近閲覧した銘柄